Pre-Budget 2017 Submission
Cancer Trials Ireland calls for a €1 million fund to boost cancer trials
In its pre-Budget 2017 submission, Cancer Trials Ireland has called for the establishment of a €1 million fund to enable cancer specialists open more cancer trials in Ireland.
eHealth and cancer trials
Cancer Trials Ireland CEO, Eibhlin Mulroe, and member of the eHealth Ireland Committee talks about the importance of eHealth in Cancer Trials. Click photo.
Decoding Cancer: Multiple Myeloma
Shortage of trials is biggest barrier for patients
Call for ‘physician champions’
Dr Cathy Kelly, Consultant Medical Oncologist at the Mater Hospital,one of the study's authors.
A study by the Medical Oncology Department at the Mater Hospital, Dublin, in association with Cancer Trials Ireland, has found that the biggest barrier to patients participating in cancer trials is the availability of suitable cancer trials.
The study found that there was no cancer trial option available for the majority of patients (71%) studied because the trials that were open did not meet their specific cancer type, the stage of their disease and their line of treatment.
Participants talk about cancer trials
Cancer Trials Ireland has launched a series of 6 shorts videos which involve people talking directly about their experience taking part in a cancer trial.
The videos are available to view at Cancer Trials Ireland’s website. http://www.cancertrials.ie/about-us/why-cancer-trials1
European breast cancer trial opens in Ireland
Cancer Trials Ireland has opened the Irish arm of a European breast cancer trial to test the effectiveness of a new combination of drugs as a first line treatment for advanced breast cancer.
Known as The FLIPPER Study, the trial is sponsored by GEICAM, the Spanish Breast Cancer Group, and will involve 190 patients across Europe, with 40 from Ireland.
The trial will investigate the added benefit of combining the new drug palbociclib with an existing drug fulvestrant. Fulvestrant is currently used to treat postmenopausal women with hormone receptor (HR)-positive advanced breast cancer.
Cancer Trials Ireland has been conducting cancer trials with local and global pharmaceutical partners for many years.
We have a wealth of experience and expertise to deliver cancer trials success.
If you would like to find out more about how we can work together please contact:
- Business Development Manager
- Email: firstname.lastname@example.org